,

Qi Wei1,2, AiMin Liu2, ZhiYong Sun2

  • 1Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China; Anhui Medical University and Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, People's Republic of China.

概括

手术前的中性粒细胞与淋巴细胞的比率 (NLR),血小板与淋巴细胞的比率 (PLR) 和全身免疫炎症指数 (SII) 预测皮肤透神经切除术 (PCNL) 后的全身炎症反应综合征 (SIRS). 这些生物标志物有助于风险分层,以改善患者管理.